Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact
Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact
Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact
Submitted by
admin
on April 19, 2017 - 4:17pm
Source:
Endpoints
News Tags:
Bristol-Myers Squibb
cancer
vaccines
Bavarian Nordic
Prostvac
Opdivo
Yervoy
Headline:
Bristol-Myers preps second checkpoint/cancer vax combo study under its $1B Bavarian Nordic pact
Do Not Allow Advertisers to Use My Personal information
